> Well, it's in mice first of all. And it has nothing to do with the mRNA vaccines that are popular right now. So it's a novel strategy for vaccines. And it se

> Well, it's in mice first of all. And it has nothing to do with the mRNA vaccines that are popular right now. So it's a novel strategy for vaccines. And it seems to be working. That combo should qualify as "breakthrough" I think? Sure, it may fail later on in clinical trials. But potentially a huge step forward.